U.S. Securities and Exchange Commission v. Spartan Securities Group, LTD.

District Court, M.D. Florida·Decided May 26, 2021·No. 8:19-cv-00448·Unknown

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION

UNITED STATES SECURITIES & EXCHANGE COMMISSION,

Plaintiff,

v. Case No. 8:19-cv-448-VMC-CPT

SPARTAN SECURITIES GROUP, LTD, ISLAND CAPITAL MANAGEMENT, CARL DILLEY, MICAH ELDRED, and DAVID LOPEZ,

Defendants.

______________________________/

ORDER

This matter comes before the Court pursuant to Plaintiff Securities and Exchange Commission’s (SEC) Omnibus Motion in Limine (Doc. # 123) and Defendants’ Omnibus Motion in Limine (Doc. # 124), both filed on November 6, 2020. Both sides responded on November 20, 2020. (Doc. ## 128, 131). For the reasons that follow, the SEC’s Motion is granted in part and denied in part and Defendants’ Motion is denied without prejudice. I. Background The SEC initiated this action against Defendants on February 20, 2019. (Doc. # 1). In its fourteen-count complaint, the SEC accuses Defendants of engaging in two separate micro-cap fraud schemes in violation of the Securities Act of 1933 (Securities Act) and the Securities Exchange Act of 1934 (Exchange Act). Specifically, the SEC alleges that Defendants violated — and aided and abetted violations of — Section 15(c)(2) and Rule 15c2-11 of the Exchange Act (Counts 1 and 2), Section 17(a) of the Securities Act (Counts 3-4, 8-10), Section 10(b) and Rule 10b-5 of the Exchange Act (Counts 5-7, 11-13), and Sections 5(a) and 5(c)

of the Securities Act (Count 14). (Id.). The Court denied the parties’ cross-motions for summary judgment on December 28, 2020. (Doc. # 135). Now, both sides move to exclude the introduction of various evidence and arguments at trial. (Doc. ## 123, 124). All parties have responded (Doc. ## 128, 131) and the Motions are ripe for review. II. Legal Standard “A motion in limine presents a pretrial issue of admissibility of evidence that is likely to arise at trial, and as such, the order, like any other interlocutory order, remains subject to reconsideration by the court throughout

the trial.” In re Seroquel Prods. Liab. Litig., Nos. 6:06– md–1769–ACC-DAB, 6:07–cv–15733–ACC-DAB, 2009 WL 260989, at *1 (M.D. Fla. Feb. 4, 2009). “The real purpose of a motion in limine is to give the trial judge notice of the movant’s position so as to avoid the introduction of damaging evidence which may irretrievably [a]ffect the fairness of the trial.” Id. (internal quotation omitted). “A court has the power to exclude evidence in limine only when evidence is clearly inadmissible on all potential grounds.” Id. (internal quotation omitted). “A motion in limine is not the proper vehicle to resolve

substantive issues, to test issues of law, or to address or narrow the issues to be tried.” LSQ Funding Grp. v. EDS Field Servs., 879 F. Supp. 2d 1320, 1337 (M.D. Fla. 2012)(internal citation omitted). “Denial of a motion in limine does not necessarily mean that all evidence contemplated by the motion will be admitted at trial.” In re Seroquel, 2009 WL 260989, at *1 (internal quotations omitted). “Instead, denial of the motion means the court cannot determine whether the evidence in question should be excluded outside the trial context.” Id. “The court will entertain objections on individual proffers as they arise at trial, even though the proffer falls within the scope of a denied motion in limine.” Id.

The district court has broad discretion to determine the admissibility of evidence, and the appellate court will not disturb this Court’s judgment absent a clear abuse of discretion. United States v. McLean, 138 F.3d 1398, 1403 (11th Cir. 1998); see also United States v. Jernigan, 341 F.3d 1273, 1285 (11th Cir. 2003)(“Inherent in this standard is the firm recognition that there are difficult evidentiary rulings that turn on matters uniquely within the purview of the district court, which has first-hand access to documentary evidence and is physically proximate to testifying witnesses and the jury.”).

III. Analysis A. The SEC’s Omnibus Motion in Limine The SEC seeks exclusion of eight categories of evidence. (Doc. # 123). The Court addresses each in turn. 1. Mark Harmon’s Testimony on “Irrelevant Topics” First, the SEC seeks to exclude as irrelevant and misleading Mark Harmon’s testimony on, and counsel’s arguments related to, 1. [T]he application of UCC 8-401 and 17 C.F.R. § 240.17Ad, or other laws not charged in this case; 2. [C]ompliance with various other state and federal regulations which purportedly restrict a transfer agent’s ability to examine critically the facts and circumstances underlying documentation; 3. [T]he fact that transfer agents purportedly perform only ministerial functions and lack investigatory powers. (Doc. # 123 at 2-4). Defendants respond that such testimony is relevant insofar as it will guide the jury’s understanding of the securities industry and help contextualize the alleged violations at issue in this case. (Doc. # 128 at 3-4). The Court addressed these issues in detail on November 30, 2020, when it ruled on the SEC’s motion to exclude the expert testimony of Mark Harmon. (Doc. # 133). For the same reason the Court granted that motion in part, it grants the

instant Motion to the extent that witnesses, including expert witness Mark Harmon, “may not opine on the reasonableness of [Defendants’] conduct, [Defendants’] legal obligations under federal law, or [Defendants’] compliance with federal law.” (Id. at 20-21). However, at this time the Court will not exclude evidence or arguments on the “general background [of] relevant statutory and regulatory schemes,” “the decision-making process transfer agents generally follow,” and the “kind of regulatory and legal considerations transfer agents usually take into account when evaluating transfers.” (Id.). The Court agrees with Defendants that such evidence could bear on

the reasonableness of Defendants’ actions and help contextualize Harmon’s testimony. That portion of the Motion is denied without prejudice and the SEC may make more specific objections as Harmon’s testimony develops at trial. 2. “References to Charging Decisions” Next, the SEC seeks to exclude as irrelevant any reference to the SEC’s “exercise of discretion to charge, or not to charge, entities and individuals involved in or related to the Commission’s investigation and this subsequent litigation.” (Doc. # 123 at 5). Defendants respond that they “do not intend to make any

[such] arguments.” (Doc. # 128 at 5). Instead, Defendants “intend to argue a related but separate issue that tangentially relates to charging decisions — that examiners for [the] SEC and [the] Financial Industry Regulatory Authority (‘FINRA’) reviewed many of the documents and materials [the] SEC is likely to rely on at trial and those examiners did not find evidence of the fraud [the] SEC now alleges.” (Id.). The Court agrees with Defendants that evidence of prior investigations — and regulatory agencies’ subsequent decision to charge or not charge Defendants in the wake of those investigations — could go to the issue of scienter.

Specifically, the fact that FINRA and the SEC previously investigated Defendants, but chose not to pursue an enforcement action, could support Defendants’ contention that they were justifiably unaware of any fraud occurring, and thus their actions were not severely reckless. At this juncture, the Court cannot determine whether the probative value of such evidence is outweighed by the risk of undue prejudice or misleading the jury.

Free access — add to your briefcase to read the full text and ask questions with AI

U.S. Securities and Exchange Commission v. Spartan Securities Group, LTD., (M.D. Fla. 2021).

U.S. Securities and Exchange Commission v. Spartan Securities Group, LTD. (U.S. Securities and Exchange Commission v. Spartan Securities Group, LTD.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related